Genotype-phenotype correlation in CAG-repeat diseases

Neuropathology

Volumn 22, Issue 4, 2002, Pages 317-322

  Yamada, Mitsunori ^a   Tsuji, Shoji ^a   Takahashi, Hitoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

CAG repeat disease; Dentatorubral pallidoluysian atrophy; Pathology; Polyglutamine

Indexed keywords

ADENINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYTOSINE; GENE PRODUCT; GUANINE; MUTANT PROTEIN; POLYGLUTAMINE; TATA BINDING PROTEIN;

AMINO ACID SEQUENCE; CAG REPEAT DISEASE; CELL NUCLEUS INCLUSION BODY; CLINICAL FEATURE; CONFERENCE PAPER; CORRELATION ANALYSIS; DEGENERATIVE DISEASE; DENTATORUBROPALLIDOLUYSIAN ATROPHY; GENE MUTATION; GENETIC DISORDER; GENOTYPE; HUMAN; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEOTIDE REPEAT; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION;

ANIMALS; GENOTYPE; HUMANS; INCLUSION BODIES; MICE; MYOCLONIC EPILEPSIES, PROGRESSIVE; NEURONS; PEPTIDES; PHENOTYPE; TRINUCLEOTIDE REPEATS;

EID: 0036966750     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1789.2002.00457.x     Document Type: Conference Paper

References (43)

1. Ross CA. When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases. Neuron 1995; 15: 493-496.
2. Tsuji S. Unstable expansion of triplet repeats as a new disease mechanism for neurodegenerative diseases. Jpn J Hum Genet 1996; 41: 279-290.
3. Paulson HL, Fischbeck KH. Trinucleotide repeats in neurogenetic disorders. Ann Rev Neurosci 1996; 19: 79-107.
4. Gusella JF, Persichetti F, MacDonald ME. The genetic defect causing Huntington's disease: repeated in other contexts? Mol Med 1997; 3: 238-246.
5. Koide R, Ikeuchi T, Onodera O, et al. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet 1994; 6: 9-13.
6. Nagafuchi S, Yanagisawa H, Sato K, et al. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet 1994; 6: 14-18.
7. Naito H, Oyanagi S. Familial myoclonus epilepsy and choreoathetosis: hereditary dentatorubral-pallidoluysian atrophy. Neurology 1982; 32: 798-807.
8. Takahashi H, Ohama E, Naito H, et al. Hereditary dentatorubral-pallidoluysian atrophy: clinical and pathologic variants in a family. Neurology 1988; 38: 1065-1070.
9. Davies SW, Turmaine M, Cozens BA, et al. Formation of intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997; 90: 537-548.
10. DiFiglia M, Sapp E, Chase KO, et al. Aggregation of Huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997; 277: 1990-1993.
11. Skinner PJ, Koshy BT, Cummings CJ, et al. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 1997; 389: 971-974.
12. Paulson HL, Perez MK, Trottier Y, et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 1997; 19: 333-344.
13. Holmberg M, Duyckaerts C, Dürr A, et al. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum Mol Genet 1998; 7: 913-918.
14. Hayashi Y, Kakita A, Yamada M, et al. Hereditary dentatorubral-pallidoluysian atrophy: detection of widespread ubiquitinated neuronal and glial intranuclear inclusions in the brain. Acta Neuropathol 1998; 96: 547-552.
15. Igarashi S, Koide R, Shimohata T, et al. Suppression of aggregate formation and apoptosis by transglutaminase inhibitions in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat Genet 1998; 18: 111-117.
16. Koyano S, Uchihara T, Fujigasaki H, et al. Neuronal intranuclear inclusions in spinocerebellar ataxia type 2: triple-labeling immunofluorescent study. Neurosci Lett 1999; 273: 117-120.
17. Mangiarini L, Sathasivam K, Seller M, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996; 87: 493-506.
18. Warrick JM, Paulson HL, Gray-Board GL, et al. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 1998; 93: 939-949.
19. Ross CA, Wood JD, Schilling G, et al. Polyglutamine pathogenesis. Phil Trans R Soc Lond B 1999; 354: 1005-1011.
20. Schilling G, Becher MW, Sharp AH, et al. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 1999; 8: 397-407.
21. Schilling G, Wood JD, Duan K, et al. Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA. Neuron 1999; 24: 275-286.
22. Ross CA. Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 1997; 19: 1147-1150.
23. Yamada M, Sato T, Shimohata T, et al. Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases. Am J Pathol 2001; 159: 1785-1795.
24. Cummings CJ, Reinstein E, Sun Y, et al. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron 1999; 24: 879-892.
25. Klement IA, Skinner PJ, Kaytor MD, et al. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 1998; 95: 41-53.
26. Saudou F, Finkbeiner S, Devys D, Greenberg ME. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 1998; 95: 55-66.
27. Yamada M, Wood JD, Shimohata T, et al. Widespread occurrence of intranuclear atrophin-1 accumulation in the central nervous system neurons of patients with dentatorubral-pallidoluysian atrophy. Ann Neurol 2001; 49: 14-23.
28. Arai T, Mizukami K, Matsuzaka H, Iwakuma A, Shiraishi H, Koizumi J. CNS changes in DRPLA with dementia and personality changes. CT, MR and SPECT findings. Jpn J Psychiatry Neurol 1993; 47: 105-110.
29. Tokiguchi S, Naito H, Nagai H. CT findings of hereditary dentatorubral-pallidoluysian atrophy (DRPLA). CT Kenkyu 1987; 9: 665-672.
30. Koide R, Onodera O, Ikeuchi T, et al. Atrophy of the cerebellum and brainstem in dentatorubral pallidoluysian atrophy. Influence of CAG repeat size on MRI findings. Neurol 1997; 49: 1605-1612.
31. Uyama E, Kondo I, Uchino M, et al. Dentatorubral-pallidoluysian atrophy (DRPLA): clinical, genetic, and neuroradiologic studies in a family. J Neurol Sci 1995; 130: 146-153.
32. Deguchi K, Takeuchi H, Yamada A, Sasaki I, Nishioka M. The brainstem legion in hereditary dentatorubro-pallidoluysian atrophy. Shinkeinaika 1995; 42: 467-469.
33. Imamura A, Ito R, Tanaka S, et al. High-intensity proton and T2-weighted MRI signals in the globus pallidus in juvenile-type of dentatorubral and pallidoluysian atrophy. Neuropediatrics 1994; 25: 234-237.
34. Yamada M, Tsuji S, Takahashi H. Pathology of CAG repeat diseases. Neuropathol 2000; 20: 319-325.
35. Yamada M, Hayashi S, Tsuji S, Takahashi H. Involvement of the cerebral cortex and autonomic ganglia in Machado-Joseph disease. Acta Neuropathol 2001; 101: 140-144.
36. Sato T, Oyake M, Nakamura K, et al. Transgenic mice harboring a full-length human mutant DRPLA gene exhibit age-dependent intergenerational and somatic instabilities of CAG repeats comparable with those in DRPLA patients. Hum Mol Genet 1999; 8: 99-106.
37. Sato T, Yamada M, Oyake M, et al. Transgenic mice harboring a full-length human DRPLA gene with highly expanded CAG repeats exhibit severe disease phenotype. Am J Hum Genet 1999; 65 (Suppl.): A30.
38. Davies SW, Turmaine M, Cozens BA, et al. From neuronal inclusions to neurodegeneration. Neuropathological investigation of a transgenic mouse model of Huntington's disease. Philos Trans R Soc Lond B Biol Sci 1999; 354: 981-989.
39. 1130, interfering with CREB-dependent transcription. Nat Genet 2000; 26: 29-36.
40. Nucifora FC Jr, Sasaki M, Peters MF, et al. Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity. Science 2001; 291: 2423-2428.
41. Kazantsev A, Preisinger E, Dranovsky A, Goldgaber D, Housman D. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc Natl Acad Sci USA 1999; 96: 11 404-11 409.
42. Li SH, Cheng AL, Zhou H, et al. Interaction of Huntington disease protein with transcriptional activator Sp1. Mol Cell Biol 2002; 22: 1277-1287.
43. Yu ZX, Li SH, Nguyen HP, Li XJ. Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice. Hum Mol Genet 2002; 11: 905-914.